Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP and Microneedling for Facial and Hand Skin Rejuvenation
NCT03647917Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Jun 2019
- Primary completion
- Jun 2021
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of autologous platelet-rich plasma in Skin aging (2 arms), sponsored by Mayo Clinic. Primary endpoint: Wrinkle Severity Rating Scale at 24 weeks. Started Jun 2019; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
Skin aging
Beyond the preview
Go deeper on NCT03647917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03647917.